The Latin America, Middle East and Africa Recombinant Proteins Market should witness market growth of 14.0% CAGR during the forecast period (2022-2028).
The desire for novel, tailored medications, rise in cancer patients, and other industrial requirements like detergent and diagnostics are all projected to contribute to the total recombinant protein market experiencing considerable growth throughout the forecast period. In addition, subsequent generations of recombinant proteins made some advancements over the prior generation.
The second generation of recombinant proteins included proteins with improved qualities including selectivity, biodistribution, and efficacy, similar to the first generation, which included native protein structures. The third generation of recombinant proteins also included new formulations and administration methods with improved efficacy and security. Therefore, product innovation is the main driver of the recombinant protein market's expansion.
The United Arab Emirates has transformed into a prosperous, modern nation with a Western way of life from a developing nation with a sizable nomadic population. Certainly, this economic development has given UAE inhabitants social benefits and possibilities, including a high and rising life expectancy. But, a serious issue with chronic diseases, notably cardiovascular risk associated with obesity, has been exacerbated by fast industrialization and urbanization.
The Brazil market dominated the LAMEA Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.3 million by 2028. The Argentina market is experiencing a CAGR of 14.6% during (2022-2028). Additionally, The UAE market would display a CAGR of 13.6% during (2022-2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
The desire for novel, tailored medications, rise in cancer patients, and other industrial requirements like detergent and diagnostics are all projected to contribute to the total recombinant protein market experiencing considerable growth throughout the forecast period. In addition, subsequent generations of recombinant proteins made some advancements over the prior generation.
The second generation of recombinant proteins included proteins with improved qualities including selectivity, biodistribution, and efficacy, similar to the first generation, which included native protein structures. The third generation of recombinant proteins also included new formulations and administration methods with improved efficacy and security. Therefore, product innovation is the main driver of the recombinant protein market's expansion.
The United Arab Emirates has transformed into a prosperous, modern nation with a Western way of life from a developing nation with a sizable nomadic population. Certainly, this economic development has given UAE inhabitants social benefits and possibilities, including a high and rising life expectancy. But, a serious issue with chronic diseases, notably cardiovascular risk associated with obesity, has been exacerbated by fast industrialization and urbanization.
The Brazil market dominated the LAMEA Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.3 million by 2028. The Argentina market is experiencing a CAGR of 14.6% during (2022-2028). Additionally, The UAE market would display a CAGR of 13.6% during (2022-2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
Scope of the Study
By Product
- Growth Factors & Chemokines
- Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
- Structural Proteins
- Membrane Proteins
- Kinase Proteins & Regulatory Proteins
- Immune Response Proteins
- Others
By End-user
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
By Application
- Drug Discovery & Development
- Academic Research Studies
- Biopharmaceutical Production
- Diagnostics
- Biotechnology Research
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Recombinant Proteins Market, by Product
1.4.2 LAMEA Recombinant Proteins Market, by End User
1.4.3 LAMEA Recombinant Proteins Market, by Application
1.4.4 LAMEA Recombinant Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Recombinant Proteins Market
Chapter 4. LAMEA Recombinant Proteins Market by Product
4.1 LAMEA Growth Factors & Chemokines Market by Country
4.2 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
4.3 LAMEA Structural Proteins Market by Country
4.4 LAMEA Membrane Proteins Market by Country
4.5 LAMEA Kinase Proteins & Regulatory Proteins Market by Country
4.6 LAMEA Immune Response Proteins Market by Country
4.7 LAMEA Others Market by Country
Chapter 5. LAMEA Recombinant Proteins Market by End User
5.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 LAMEA Biotechnology Companies Market by Country
5.3 LAMEA Academic Research Institutes Market by Country
5.4 LAMEA Contract Research Organizations Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Recombinant Proteins Market by Application
6.1 LAMEA Drug Discovery & Development Market by Country
6.2 LAMEA Academic Research Studies Market by Country
6.3 LAMEA Biopharmaceutical Production Market by Country
6.4 LAMEA Diagnostics Market by Country
6.5 LAMEA Biotechnology Research Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Recombinant Proteins Market by Country
7.1 Brazil Recombinant Proteins Market
7.1.1 Brazil Recombinant Proteins Market by Product
7.1.2 Brazil Recombinant Proteins Market by End User
7.1.3 Brazil Recombinant Proteins Market by Application
7.2 Argentina Recombinant Proteins Market
7.2.1 Argentina Recombinant Proteins Market by Product
7.2.2 Argentina Recombinant Proteins Market by End User
7.2.3 Argentina Recombinant Proteins Market by Application
7.3 UAE Recombinant Proteins Market
7.3.1 UAE Recombinant Proteins Market by Product
7.3.2 UAE Recombinant Proteins Market by End User
7.3.3 UAE Recombinant Proteins Market by Application
7.4 Saudi Arabia Recombinant Proteins Market
7.4.1 Saudi Arabia Recombinant Proteins Market by Product
7.4.2 Saudi Arabia Recombinant Proteins Market by End User
7.4.3 Saudi Arabia Recombinant Proteins Market by Application
7.5 South Africa Recombinant Proteins Market
7.5.1 South Africa Recombinant Proteins Market by Product
7.5.2 South Africa Recombinant Proteins Market by End User
7.5.3 South Africa Recombinant Proteins Market by Application
7.6 Nigeria Recombinant Proteins Market
7.6.1 Nigeria Recombinant Proteins Market by Product
7.6.2 Nigeria Recombinant Proteins Market by End User
7.6.3 Nigeria Recombinant Proteins Market by Application
7.7 Rest of LAMEA Recombinant Proteins Market
7.7.1 Rest of LAMEA Recombinant Proteins Market by Product
7.7.2 Rest of LAMEA Recombinant Proteins Market by End User
7.7.3 Rest of LAMEA Recombinant Proteins Market by Application
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview
Companies Mentioned
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Methodology
LOADING...
